Literature DB >> 31187151

[Speech fluency disorders in childhood and adolescence].

K Neumann1.   

Abstract

Persistent speech fluency disorders, mostly stuttering and less frequently cluttering, occur in approximately 1% of children and adolescents. They considerably impair the social participation and quality of life of those affected. The German interdisciplinary evidence-based S3 guidelines provide information about the pathogenesis, diagnostics and treatment of speech fluency disorders and contain a systematic review on the efficacy of stuttering treatment. For preschool children the Lidcombe therapy shows the best evidence of efficacy. Strong evidence also exists for an indirect approach. For adolescents and recently for children aged 6‑12 years old there is a high level of evidence for speech restructuring methods, such as fluency shaping. There is weak evidence for stuttering modification procedures and for combined speech restructuring and stuttering modification approaches. Negative evidence exists for the eclectic, unspecified stuttering therapies, breathing regulation, and hypnosis, which are frequently applied in Germany. An early start of treatment is decisive.

Entities:  

Keywords:  Cluttering; Guideline; Speech disorders; Speech fluency disorders; Stuttering

Mesh:

Year:  2019        PMID: 31187151     DOI: 10.1007/s00106-019-0694-7

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  15 in total

Review 1.  Genetic bases of stuttering: the state of the art, 2011.

Authors:  Shelly Jo Kraft; Ehud Yairi
Journal:  Folia Phoniatr Logop       Date:  2012       Impact factor: 0.849

2.  Heritability and environmental effects for self-reported periods with stuttering: a twin study from Denmark.

Authors:  Corrado Fagnani; Steen Fibiger; Axel Skytthe; Jacob V B Hjelmborg
Journal:  Logoped Phoniatr Vocol       Date:  2010-11-17       Impact factor: 1.487

Review 3.  Stuttering treatment research 1970-2005: I. Systematic review incorporating trial quality assessment of behavioral, cognitive, and related approaches.

Authors:  Anne K Bothe; Jason H Davidow; Robin E Bramlett; Roger J Ingham
Journal:  Am J Speech Lang Pathol       Date:  2006-11       Impact factor: 2.408

Review 4.  Stuttering treatment research 1970-2005: II. Systematic review incorporating trial quality assessment of pharmacological approaches.

Authors:  Anne K Bothe; Jason H Davidow; Robin E Bramlett; Duska M Franic; Roger J Ingham
Journal:  Am J Speech Lang Pathol       Date:  2006-11       Impact factor: 2.408

5.  A randomized control trial to investigate the impact of the Lidcombe Program on early stuttering in German-speaking preschoolers.

Authors:  Christina Lattermann; Harald A Euler; Katrin Neumann
Journal:  J Fluency Disord       Date:  2007-12-27       Impact factor: 2.538

6.  Extended follow-up of a randomized controlled trial of the Lidcombe Program of Early Stuttering Intervention.

Authors:  Mark Jones; Mark Onslow; Ann Packman; Sue O'Brian; Anna Hearne; Shelley Williams; Tika Ormond; Ilsa Schwarz
Journal:  Int J Lang Commun Disord       Date:  2008 Nov-Dec       Impact factor: 3.020

7.  The effectiveness of stuttering treatments in Germany.

Authors:  Harald A Euler; Benjamin P Lange; Sascha Schroeder; Katrin Neumann
Journal:  J Fluency Disord       Date:  2014-01-27       Impact factor: 2.538

Review 8.  Behavioral stuttering interventions for children and adolescents: a systematic review and meta-analysis.

Authors:  Chad Nye; Martine Vanryckeghem; Jamie B Schwartz; Carl Herder; Herbert M Turner; Courtney Howard
Journal:  J Speech Lang Hear Res       Date:  2012-12-28       Impact factor: 2.297

9.  An experimental clinical trial of a cognitive-behavior therapy package for chronic stuttering.

Authors:  Ross G Menzies; Sue O'Brian; Mark Onslow; Ann Packman; Tamsen St Clare; Susan Block
Journal:  J Speech Lang Hear Res       Date:  2008-07-29       Impact factor: 2.297

10.  Behavioral treatments for children and adults who stutter: a review.

Authors:  Michael Blomgren
Journal:  Psychol Res Behav Manag       Date:  2013-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.